General Information of the Compound
Compound ID
CP0015673
Compound Name
(2S,3S)-3-[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]butane-1,2,4-triol
    Show/Hide
Synonyms
BS-194
CDK inhibitors (cancer), Imperial College London/Emory University
    Show/Hide
Structure
Formula
C20H27N5O3
Molecular Weight
385.468
Canonical SMILES
CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12
    Show/Hide
InChI
InChI=1S/C20H27N5O3/c1-13(2)15-10-22-25-19(21-9-14-6-4-3-5-7-14)8-18(24-20(15)25)23-16(11-26)17(28)12-27/h3-8,10,13,16-17,21,26-28H,9,11-12H2,1-2H3,(H,23,24)/t16-,17+/m0/s1
    Show/Hide
InChIKey
KRIWIRSMQRQYJG-DLBZAZTESA-N
Physicochemical Property
logP
1.5908
Rotatable Bonds
9
Heavy Atom Count
28
Polar Areas
114.94
Hydrogen Bond Donor Count
5
Hydrogen Bond Acceptor Count
8
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25125014
SID: 56449261
ChEMBL ID
CHEMBL1234833
Clinical Information about the Compound
Drug 1 ( BS-194 )
Drug Name BS-194
Company Imperial College London
Indication
Solid tumour/cancer
Investigative